Skip to main content
Clinical Trials/JPRN-jRCT1051230087
JPRN-jRCT1051230087
Recruiting
Phase 1

Clinical trial to evaluate the safety and feasibility of online adaptive intensity-modulated radiotherapy with concurrent chemotherapy using cone-beam CT for pancreatic cancer

Mizowaki Takashi0 sites10 target enrollmentAugust 18, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Mizowaki Takashi
Enrollment
10
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mizowaki Takashi

Eligibility Criteria

Inclusion Criteria

  • 1\. Confirmed pancreatic adenocarcinoma by endoscopic ultrasound\-fine needle aspiration.
  • 2\. Patients with borderline resectable pancreatic cancer or locally advance pancreatic cancer.
  • 3\. Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1

Exclusion Criteria

  • 1\. Patients who have received radiotherapy to upper abdomen.
  • 2\. Tumor with direct invasion to stomach, duodenum, or small intestine.
  • 3\. Patients who cannot be treated expiratory breath\-hold technique.

Outcomes

Primary Outcomes

Not specified

Similar Trials